GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Link Pharma Chem Ltd (BOM:524748) » Definitions » 3-Year Revenue Growth Rate

Link Pharma Chem (BOM:524748) 3-Year Revenue Growth Rate : 15.00% (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Link Pharma Chem 3-Year Revenue Growth Rate?

Link Pharma Chem's Revenue per Share for the three months ended in Dec. 2023 was ₹17.95.

During the past 12 months, Link Pharma Chem's average Revenue per Share Growth Rate was -23.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 15.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 15.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 11.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Link Pharma Chem was 29.80% per year. The lowest was -12.00% per year. And the median was 13.90% per year.


Competitive Comparison of Link Pharma Chem's 3-Year Revenue Growth Rate

For the Chemicals subindustry, Link Pharma Chem's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Link Pharma Chem's 3-Year Revenue Growth Rate Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Link Pharma Chem's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Link Pharma Chem's 3-Year Revenue Growth Rate falls into.



Link Pharma Chem 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Link Pharma Chem  (BOM:524748) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Link Pharma Chem 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Link Pharma Chem's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Link Pharma Chem (BOM:524748) Business Description

Traded in Other Exchanges
N/A
Address
161 - 162, GIDC Estate, Nandesari Industrial Estate, Nandesari, Vadodara, GJ, IND, 391340
Link Pharma Chem Ltd is a chemical manufacturing company in India. The company is engaged in the manufacturing and exporting of multi-range intermediates for pharmaceuticals, agro-industries, and specialty chemicals. It is also engaged in custom synthesis/contract manufacturing for multistage synthesis for a range of companies. It operates through one single segment which is Chemical manufacturing and generates revenue from the same. The company generates the majority of its revenue from domestic sales.

Link Pharma Chem (BOM:524748) Headlines

No Headlines